Chronic non-atrophic gastritis with bile reflux treatment

Written by Si Li Li
Gastroenterology
Updated on April 06, 2025
00:00
00:00

Chronic non-atrophic gastritis with bile reflux is mainly characterized by symptoms such as upper abdominal distension, belching, acid reflux, nausea, vomiting, poor appetite, and indigestion. A diagnosis can be made if bile reflux into the stomach or bile patches on the stomach wall are observed during gastroscopy. A Carbon-14 breath test is also necessary to determine the presence of Helicobacter pylori infection. If the infection test is positive, a 14-day anti-Helicobacter pylori treatment is required. Additionally, treatment for chronic non-atrophic gastritis with bile reflux should include acid suppression, gastric protection, and promotion of gastric motility to protect the gastric mucosa, with a treatment duration of about four to six weeks. Bile reflux-associated chronic gastritis is primarily caused by poor gastric motility, thus increasing physical exercise is recommended as it can enhance gastric motility and improve the condition.

Other Voices

doctor image
home-news-image
Written by Si Li Li
Gastroenterology
1min 9sec home-news-image

Is atrophic gastritis of the gastric antrum serious?

Atrophic gastritis is a chronic gastric disease characterized by repeated damage to the gastric mucosal epithelium, leading to the atrophy of the intrinsic glands, with or without intestinal metaplasia or pseudopyloric gland metaplasia. The main cause of this disease is infection by Helicobacter pylori. Symptoms primarily include upper abdominal distension, belching, acid reflux, early satiety, nausea, etc. Some patients may experience symptoms such as weight loss, fatigue, memory loss, anxiety, and depression. The main treatment involves eradicating Helicobacter pylori, suppressing acid production, and using gastric mucosal protectants and prokinetic agents. The majority of patients have Helicobacter pylori-related gastritis, which after chronic inflammation (chronic non-atrophic gastritis) can lead to atrophic gastritis, followed by intestinal metaplasia or dysplasia, and eventually may progress to gastric cancer.

doctor image
home-news-image
Written by Jiang Guo Ming
Gastroenterology
1min 28sec home-news-image

Is atrophic gastritis serious?

Chronic atrophic gastritis, compared to chronic non-atrophic gastritis, is relatively more severe. It is usually due to the atrophy of the gastric mucosal glands that this condition occurs. Under gastroscopy, the gastric mucosa can be seen to become pale, and the submucosal blood vessels are easily exposed. Sometimes, the gastric mucosal cells are replaced by intestinal epithelial cells, which is what we refer to as intestinal metaplasia. Some believe that this condition is a precancerous lesion, so it must be given sufficient attention. Firstly, it is necessary to check for Helicobacter pylori infection; if present, comprehensive antibiotic treatment is required. Some believe that if Helicobacter pylori is completely eradicated, partial reversal of gastric mucosal atrophy can happen, and in some cases, it may even return to normal, making the eradication of Helicobacter pylori particularly important. If there is no Helicobacter pylori infection, symptomatic treatment is advocated, such as protecting the gastric mucosa, etc. Additionally, traditional Chinese medicine has relatively better effects in treating atrophic gastritis compared to Western medicine, and further diagnosis and treatment in a traditional Chinese medicine department can be considered. (Note: The use of medications should be under the guidance of a professional doctor.)

doctor image
home-news-image
Written by Jiang Guo Ming
Gastroenterology
49sec home-news-image

Atrophic gastritis with intestinal metaplasia what medicine to take

Chronic atrophic gastritis with intestinal metaplasia often arises from untreated chronic superficial gastritis, primarily due to Helicobacter pylori infection. Therefore, it is essential to first check for Helicobacter pylori infection. If an infection is present, quadruple therapy is generally used to eradicate the bacteria, which may improve the atrophy. If there is no Helicobacter pylori infection, treatment mainly involves protecting the gastric mucosa. While there are no specific Western medicines for this, traditional Chinese medicine and a differential diagnosis approach often yield good results. Regular follow-ups are also important. (Specific medications should be used under the guidance of a doctor.)

doctor image
home-news-image
Written by Ren Zheng Xin
Gastroenterology
45sec home-news-image

What are the symptoms of atrophic gastritis?

Atrophic gastritis, also known as body-type gastritis, is mainly caused by Helicobacter pylori infection leading to atrophy of the gastric mucosa. Under microscopy, twisted blood vessels and alternating red and white mucosa can be seen. The main symptoms include nausea, vomiting, and decreased appetite. A reduction in parietal cells can lead to decreased secretion of intrinsic factor, thereby causing anemia with red blood cells. If atrophic gastritis is accompanied by ulcers, it can cause severe abdominal pain and bloody stools. It is important to adjust the diet, eat more soft and easily digestible foods, and consume fewer raw, cold, and spicy foods.

doctor image
home-news-image
Written by Wu Hai Wu
Gastroenterology
54sec home-news-image

What should I do if atrophic gastritis causes severe weight loss?

Patients with atrophic gastritis should be highly attentive if they experience significant weight loss and should receive standardized traditional treatments. Additionally, dietary habits also require careful attention; it is important to quit smoking and drinking alcohol, and to avoid using medications that damage the gastric mucosa, such as nonsteroidal anti-inflammatory drugs and steroids. Furthermore, eating habits should be regular, avoiding binge eating and foods that are too salty, spicy, or that are fried or deep-fried. Active treatment should also be directed against Helicobacter pylori, utilizing medications that protect the gastric mucosa, enhance its resistance to gastric acid, and improve the regenerative ability of gastric mucosal cells. Medications that inhibit bile reflux and improve gastric motility can also be employed.